These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2849960)
1. Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination. Martin A; Wychowski C; Benichou D; Crainic R; Girard M Ann Inst Pasteur Virol; 1988; 139(1):79-88. PubMed ID: 2849960 [TBL] [Abstract][Full Text] [Related]
2. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1. Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609 [TBL] [Abstract][Full Text] [Related]
3. Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted. Couderc T; Martin A; Wychowski C; Girard M; Horaud F; Crainic R J Gen Virol; 1991 Apr; 72 ( Pt 4)():973-7. PubMed ID: 1707949 [TBL] [Abstract][Full Text] [Related]
4. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. La Monica N; Meriam C; Racaniello VR J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384 [TBL] [Abstract][Full Text] [Related]
5. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704 [TBL] [Abstract][Full Text] [Related]
6. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152. Wiegers K; Uhlig H; Dernick R Virology; 1989 Jun; 170(2):583-6. PubMed ID: 2471354 [TBL] [Abstract][Full Text] [Related]
7. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Murray MG; Bradley J; Yang XF; Wimmer E; Moss EG; Racaniello VR Science; 1988 Jul; 241(4862):213-5. PubMed ID: 2838906 [TBL] [Abstract][Full Text] [Related]
8. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. Martin A; Wychowski C; Couderc T; Crainic R; Hogle J; Girard M EMBO J; 1988 Sep; 7(9):2839-47. PubMed ID: 2460345 [TBL] [Abstract][Full Text] [Related]
9. Expression of a poliovirus neutralization epitope at the surface of recombinant bacteria: first immunization results. Charbit A; Van der Werf S; Mimic V; Boulain JC; Girard M; Hofnung M Ann Inst Pasteur Microbiol; 1988; 139(1):45-58. PubMed ID: 2454645 [TBL] [Abstract][Full Text] [Related]
10. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957 [TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid. Altmeyer R; Murdin AD; Harber JJ; Wimmer E Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493 [TBL] [Abstract][Full Text] [Related]
12. Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria. van der Werf S; Charbit A; Leclerc C; Mimic V; Ronco J; Girard M; Hofnung M Vaccine; 1990 Jun; 8(3):269-77. PubMed ID: 1694613 [TBL] [Abstract][Full Text] [Related]
13. Antigenic structure of polioviruses of serotypes 1, 2 and 3. Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046 [TBL] [Abstract][Full Text] [Related]
14. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. Leclerc C; Deriaud E; Mimic V; van der Werf S J Virol; 1991 Feb; 65(2):711-8. PubMed ID: 1702841 [TBL] [Abstract][Full Text] [Related]
16. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. van der Werf S; Wychowski C; Bruneau P; Blondel B; Crainic R; Horodniceanu F; Girard M Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5080-4. PubMed ID: 6308670 [TBL] [Abstract][Full Text] [Related]
17. A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1. Wychowski C; van der Werf S; Siffert O; Crainic R; Bruneau P; Girard M EMBO J; 1983; 2(11):2019-24. PubMed ID: 6196195 [TBL] [Abstract][Full Text] [Related]
18. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244 [TBL] [Abstract][Full Text] [Related]
19. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084 [TBL] [Abstract][Full Text] [Related]
20. Location and primary structure of a major antigenic site for poliovirus neutralization. Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]